Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST)

References

• World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance 2014; Antimicrobial Resistance Global Surveillance Report. Geneva, Switzerland: WHO; 2014.
   Google Scholar
• Kolditz M, Tesch F, Mocke L, Höffken G, Ewig S, Schmitt J. Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study. Respir Med. 2016;121:32–38. doi:10.1016/j.rmed.2016.10.01527888989
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Pediatrics Collaboration; Kyu HH, Pinho C, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study. JAMA Pediatr. 2016;170(3):267–287. doi:10.1001/jamapediatrics.2015.388626810619
   PubMed Web of Science ®Google Scholar
• Maddi S, Kolsum U, Jackson S, et al. Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK. Int J Chron Obstruct Pulmon Dis. 2017;12:1507–1518. doi:10.2147/COPD.S15088728579769
   PubMed Web of Science ®Google Scholar
• Zuníno C, Vomero A, Pandolfo S, et al. Etiology and evolution of the osteoarticular infections 2009–2015:pediatric Hospital Pereira Rossell Uruguay. Rev Chilena Infectol. 2017;34(3):235–242. doi:10.4067/S0716-1018201700030000528991319
   PubMed Web of Science ®Google Scholar
• Jiang H, Su M, Kui L, et al. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012–2015. PLoS One. 2017;12(6):e0180161. doi:10.1371/journal.pone.018016128662145
   PubMed Web of Science ®Google Scholar
• Cho YC, Chiu NC, Huang FY, et al. Epidemiology and antimicrobial susceptibility of non-typeable Haemophilus influenzae in otitis media in Taiwanese children. J Micro Immu and Infec. 2017;S1684–S1182(17):30203–30207.
   Google Scholar
• Viktorija T, Michael JD. Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004–2008). Anna Clin Micro and Antimicrob. 2014;13:52–59.
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard. 8thed. Document M7-A8 Wayne, PA: Clinical and Laboretory Standarda Institute; 2009.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 20thed. Document M100-S27 Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Pfizer Inc. (Wyeth Pharmaceuticals). TygacilProduct Insert [Internet]. Philadelphia, PA: Pfizer Inc.; 2013 Available from: http://www.pfizerpro.com/hcp/tygacil
   Google Scholar
• Tian L, Sun Z, Zhang Z. Antimicrobial resistance of pathogens causing nosocomial bloodstream infectionin Hubei Province, China, from 2014 to2016: a multicenter retrospective study. BMC Public Health. 2018;8(1):1121–1128. doi:10.1186/s12889-018-6013-5
   Web of Science ®Google Scholar
• Cattoir V, Isnard C, Cosquer T, et al. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium. Antimicrob Agents Chemother. 2015;59(1):239–244. doi:10.1128/AAC.04174-1425348531
   PubMed Web of Science ®Google Scholar
• Lupien A, Gingras H, Leprohon P, Ouellette M. Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA. J Antimicrob Chemother. 2015;70(11):2973–2980. doi:10.1093/jac/dku44526183184
   PubMed Web of Science ®Google Scholar
• Schmitz J, van der Linden M, Al-Lahham A, Levina N, Pletz MW 4, Imöhl M. Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004–2005 to 2014–2015. Int J Med Microbiol. 2017;307(4–5):216–222. doi:10.1016/j.ijmm.2017.04.00328506425
   PubMed Web of Science ®Google Scholar
• Li S, Guo Y, Zhao C, et al. In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China. J Med Microbiol. 2016;65(10):1215–1224. doi:10.1099/jmm.0.00034727599998
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Huband MD, Streit J, Flamm RK, Sader HS. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016). Inter J Antimicrol Agents. 2018;51(6):848–853. doi:10.1016/j.ijantimicag.2018.01.006
   Web of Science ®Google Scholar
• Sader HS, Castanheira M, Farrell DJ, Flamm RK, Mendes RE, Jones RN. Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres:results from SENTRY Antimicrobial Surveillance Program(2011–2014). Int J Antimicrob Agents. 2016;48(2):144–150. doi:10.1016/j.ijantimicag.2016.04.02127291285
   PubMed Web of Science ®Google Scholar
• Helio SS, David JF, Robert KF, Ronald NJ. Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012). Antimicrob Chemother. 2014;58(4):2274–2280. doi:10.1128/AAC.02684-13
   Web of Science ®Google Scholar
• Mendes RE, Mendoza M, Banga SK, et al. Regional resistance surveillance program results for 12 Asia-Pacific Nations (2011). Antimicrob Chemother. 2013;57(11):5721–5726. doi:10.1128/AAC.01121-13
   Web of Science ®Google Scholar
• Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616–632.28893183
   PubMed Web of Science ®Google Scholar
• Zhao C, Li Z, Zhang F, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis. 2017;17(1):804–815. doi:10.1186/s12879-017-2880-029284419
   PubMed Web of Science ®Google Scholar
• Kim SH, Bae IK, Park D, et al. Serotype distribution and antimicrobial resistance of streptococcus pneumoniae isolates causing invasive and noninvasive pneumococcal diseases in Korea from 2008 to 2014. BioMed Research Inter. 2016;2016:6950482.
   PubMed Web of Science ®Google Scholar
• Houri H, Tabatabaei SR, Saee Y, Fallah F, Rahbar M, Karimi A. Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran. Inter J Infec Dis. 2017;57:21–26. doi:10.1016/j.ijid.2017.01.020
   Web of Science ®Google Scholar
• Songyin H, Xiaoqiang L, Weisi L, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013. BMC Infect Dis. 2015;15:312–321. doi:10.1186/s12879-015-1042-526243258
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Sader HS, Rhomberg PR, Flamm RK. In vitro activity of delafloxacin against contemporary bacterial pathogens from the United States and Europe, 2014. Antimicrob Agents Chemother. 2017;61(4):e02609–e02616. doi:10.1128/AAC.02609-1628167542
   PubMed Web of Science ®Google Scholar
• Nakano S, Fujisawa T, Ito Y, et al. Spread of meropenem-resistant Streptococcus pneumoniae Serotype 15A-ST63 Clone in Japan, 2012–2014. Emerg Infect Dis. 2018;24(2):275–283. doi:10.3201/eid2402.17126829350141
   PubMed Web of Science ®Google Scholar
• Miyazaki H, Shibuya R, Midorikawa N, Chang B, Ohnishi M, Matsumoto T. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program. J Infect Chemother. 2017;23(4):234–240. doi:10.1016/j.jiac.2016.12.01628161295
   PubMed Web of Science ®Google Scholar
• Grace EM, Marwan O, Rayane R, Fouad D, Monzer H. Molecular mechanisms and epidemiology of resistance in Streptococcus pneumoniae in the Middle East region. J Med Micro. 2017;66(7):847–858. doi:10.1099/jmm.0.000503
   Web of Science ®Google Scholar
• Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: results from the CARTIPS antimicrobial surveillance program. J Glob Antimicrob Resist. 2016;5:36–41. doi:10.1016/j.jgar.2016.03.00227436464
   PubMed Web of Science ®Google Scholar
• Torumkuney D, Chaiwarith R, Reechaipichitkul W, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore. J Antimicrob Chemother. 2016;71(Suppl1):i3–i19. doi:10.1093/jac/dkw07327048580
   PubMed Web of Science ®Google Scholar
• Iroh Tam PY, Sadoh AE, Obaro SK. A meta-analysis of antimicrobial susceptibility profiles for Pneumococcal pneumonia in sub-Saharan Africa. Paedia Inter Child Health. 2018;38(1):7–15. doi:10.1080/20469047.2017.1298700
   PubMed Web of Science ®Google Scholar
• Iroh Tam PY, Thielen BK, Obaro SK, et al. Childhood pneumococcal disease in Africa – A systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility. Vaccine. 2017;35(15):1817–1827. doi:10.1016/j.vaccine.2017.02.04528284682
   PubMed Web of Science ®Google Scholar
• Bielicki JA, Lundin R, Sharland M. Antibiotic resistance prevalence in routine bloodstream isolates from children’s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J. 2015;34(7):734–741. doi:10.1097/INF.000000000000065225607829
   PubMed Web of Science ®Google Scholar
• Schroeder MR, Stephens DS. Macrolide resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol. 2016;6:98 eCollection 2016. doi:10.3389/fcimb.2016.0009827709102
   PubMed Web of Science ®Google Scholar
• Li JP, Hua CZ, Sun LY, Wang HJ, Chen ZM, Shang SQ. Epidemiological features and antibiotic resistance patterns of Haemophilus influenzae originating from respiratory tract and vaginal specimens in pediatric patients. J Pediatr Adolesc Gynecol. 2017;30(6):626–631. doi:10.1016/j.jpag.2017.06.00228629795
   PubMed Web of Science ®Google Scholar